MN

Marie Nguyen

Professional Summary



Professional Overview


Marie Nguyen is a seasoned pharmaceutical executive with over 15 years of experience in clinical development and translational medicine. As the Vice President and Head of Clinical Development at Parabilis Medicines, she is responsible for leading the company's clinical research strategy and overseeing the execution of complex oncology and hematology trials.

Experience Summary



Current Role


In her current role at Parabilis Medicines, Marie is spearheading the clinical development of the company's innovative pipeline of targeted therapies. She is responsible for designing and implementing efficient clinical trial protocols, managing cross-functional teams, and ensuring regulatory compliance. Under her leadership, Parabilis has successfully advanced several candidates into late-stage trials, positioning the company as a emerging leader in the field of precision oncology.

Career Progression


Prior to joining Parabilis, Marie held progressively senior positions at leading pharmaceutical companies, including Bristol Myers Squibb and Celgene. As the Executive Director and Head of the R&ED Clinical Center of Excellence at Bristol Myers Squibb, she was instrumental in the successful development and approval of several oncology and cell therapy products. Earlier in her career, Marie served as a Senior Medical Director at Celgene, where she played a pivotal role in the advancement of multiple hematology and oncology programs.

Academic Background


Marie earned her medical degree from Stanford University School of Medicine and completed her residency in Internal Medicine at the University of Washington/Fred Hutchinson Cancer Research Center. She further specialized in Hematology and Oncology, completing a fellowship at Stanford University School of Medicine. Additionally, Marie holds a Master's in Epidemiology from Stanford University, where she was awarded the prestigious SPECTRUM NIH KL2 Award.

Areas of Expertise


  • Oncology and hematology drug development

  • Early-to-late stage clinical trial design and execution

  • Translational medicine and biomarker strategy

  • Cross-functional team leadership and collaboration

  • Regulatory strategy and compliance


Professional Impact


Throughout her career, Marie has made significant contributions to the development of innovative cancer therapies. Her work has led to the successful approval of several life-changing treatments, improving outcomes for patients with hematological malignancies and solid tumors. Marie is recognized as a thought leader in the industry, having served as the Chair of the American Society of Hematology Trainee Council and published extensively in peer-reviewed journals.

Conclusion


With her extensive experience, deep scientific expertise, and proven track record of delivering results, Marie Nguyen is poised to drive Parabilis Medicines' clinical development strategy and further solidify the company's position as a leader in the field of precision oncology.